Journal article
The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis
Molecular cancer research, Vol.9(7), pp.867-877
07/2011
DOI: 10.1158/1541-7786.MCR-10-0475
PMCID: PMC3140613
PMID: 21636682
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an incurable, highly metastatic disease that is largely resistant to existing treatments. A better understanding of the genetic basis of PDAC metastasis should facilitate development of improved therapies. To that end, we developed a novel mouse xenograft model of PDAC metastasis to expedite testing of candidate genes associated with the disease. Human PDAC cell lines BxPC-3, MiaPaCa-2, and Panc-1 stably expressing luciferase were generated and introduced by intracardiac injections into immunodeficient mice to model hematogenous dissemination of cancer cells. Tumor development was monitored by bioluminescence imaging. Bioluminescent MiaPaCa-2 cells most effectively recapitulated PDAC tumor development and metastatic distribution in vivo. Tumors formed in nearly 90% of mice and in multiple tissues, including normal sites of PDAC metastasis. Effects of p14ARF, a known suppressor of PDAC, were tested to validate the model. In vitro, p14ARF acted through a CtBP2-dependent, p53-independent pathway to inhibit MiaPaCa-2-invasive phenotypes, which correlated with reduced tumor cell colonization in vivo. These findings establish a new bioluminescent mouse tumor model for rapidly assessing the biological significance of suspected PDAC metastasis genes. This system may also provide a valuable platform for testing innovative therapies.
Details
- Title: Subtitle
- The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis
- Creators
- Viviane Palhares Muniz - Molecular and Cellular Biology Graduate Program, The University of Iowa, Iowa City, Iowa 52242, USAJ Matthew BarnesSeema PaliwalXuefeng ZhangXiaoyun TangSonghai ChenKokou D ZambaJoseph J CullenDavid K MeyerholzShari MeyersSteven R GrossmanMichael D HenryJ Nathan DavisDawn E Quelle
- Resource Type
- Journal article
- Publication Details
- Molecular cancer research, Vol.9(7), pp.867-877
- DOI
- 10.1158/1541-7786.MCR-10-0475
- PMID
- 21636682
- PMCID
- PMC3140613
- NLM abbreviation
- Mol Cancer Res
- ISSN
- 1541-7786
- eISSN
- 1557-3125
- Publisher
- United States
- Grant note
- I01 BX001318 / BLRD VA R01 CA090367-08 / NCI NIH HHS R01 CA090367-09 / NCI NIH HHS R21 CA127031 / NCI NIH HHS R03 CA143763 / NCI NIH HHS R21-CA127031 / NCI NIH HHS R21 CA127031-01A2 / NCI NIH HHS R01-CA090367 / NCI NIH HHS R01 CA090367-10 / NCI NIH HHS R01 CA090367 / NCI NIH HHS R21 CA127031-02 / NCI NIH HHS R03-CA143763 / NCI NIH HHS R03 CA143763-01 / NCI NIH HHS
- Language
- English
- Date published
- 07/2011
- Academic Unit
- Radiology; Molecular Physiology and Biophysics; Pathology; Iowa Neuroscience Institute; Biostatistics; Surgery; Radiation Oncology; Neuroscience and Pharmacology; Urology; Internal Medicine
- Record Identifier
- 9983997319202771
Metrics
19 Record Views